Drug eruption caused by ranitidine hydrochloride (Zantac) which showed a strong reaction in a drug-induced lymphocyte stimulation test
- 1 January 2007
- journal article
- case report
- Published by Wiley in The Journal of Dermatology
- Vol. 34 (1), 74-79
- https://doi.org/10.1111/j.1346-8138.2007.00221.x
Abstract
An 80-year-old male who developed a generalized papular erythema-type drug eruption after being treated with ranitidine hydrochloride is herein reported. The duration from the intake of the medicine to the onset of the eruption was 3 days, and the eruption remained unchanged for a week after withdrawal of the medicine and even after the eruption itself was treated. A diagnosis of drug eruption by ranitidine hydrochloride was confirmed based on a strongly-positive reaction of a drug-induced lymphocyte stimulation test (DLST).Keywords
This publication has 11 references indexed in Scilit:
- Significance of the Drug Patch Test in Identifying Causative Agents of Drug EruptionsThe Nishinihon Journal of Dermatology, 2006
- Drug Eruption Caused by Azathioprine: Value of Using the Drug‐Induced Lymphocytes Stimulation Test for DiagnosisThe Journal of Dermatology, 2004
- GENERALIZED EXANTHEMATOUS PUSTULOSIS INDUCED BY MEDICATIONSInternational Journal of Dermatology, 1996
- Cutaneous delayed reaction to ranitidineAllergy, 1996
- Lichenoid Eruptions Due to the H2-Receptor Antagonists Roxatidine and RanitidineThe Journal of Dermatology, 1996
- Ranitidine-related toxic epidermal necrolysis in a patient with idiopathic thrombocytopenic purpuraJournal of the American Academy of Dermatology, 1995
- Allergic dermatitis due to oral ranitidineContact Dermatitis, 1992
- Haematological Adverse Effects of Histamine H2-Receptor AntagonistsMedical Toxicology, 1988
- Rash mediated by immune complexes associated with ranitidine treatmentBMJ, 1988
- Urticaria from ranitidineContact Dermatitis, 1983